Reducing protein in your urine typically requires a combination of the right medication and targeted dietary changes, not one or the other. The most effective first step for most people is a class of blood pressure drugs that also protects the kidneys, paired with cutting back on sodium and moderating how much protein you eat. But the specific combination that works best depends on what is driving the protein leak in the first place, and the treatment landscape has expanded considerably in recent years with newer drugs that can be layered on top of the old standbys.
Why Protein in Urine Matters Enough to Treat
Your kidneys normally filter waste from your blood while keeping useful molecules like protein behind. When protein starts showing up in urine, it signals that the kidney’s filtering units are damaged or under stress. The cells that form the final barrier in this filtering system, called podocytes, are especially vulnerable. Once they are injured, protein leaks through, and that leak itself causes further damage to the kidney tissue downstream.1PubMed. Roles of the podocyte in glomerular function This creates a vicious cycle: more protein in the urine means more kidney damage, which means even more protein leaking out. That is why doctors treat proteinuria aggressively. The goal is not just to improve a lab number but to slow or halt the underlying kidney disease.
Doctors typically track your progress using a urine albumin-to-creatinine ratio, which can be measured from a single urine sample rather than a full 24-hour collection. A first-morning sample is preferred because it is less affected by hydration and activity during the day.2PubMed Central. Laboratory measurement of urine albumin and urine total protein in screening for proteinuria in chronic kidney disease Knowing your baseline number and watching it change over time is how you and your doctor gauge whether treatment is working.
ACE Inhibitors and ARBs Are Still the Foundation
The backbone of proteinuria treatment for decades has been a group of blood pressure medications that block the renin-angiotensin system. These drugs, known as ACE inhibitors (like lisinopril or ramipril) and ARBs (like losartan or valsartan), reduce urine protein levels through a mechanism that goes beyond simply lowering blood pressure. They relax the blood vessels inside the kidney’s filtering units, reducing the pressure that forces protein through damaged filters. A meta-analysis of randomized trials confirmed that the proteinuria reduction from these drugs is greater than what you get from other blood pressure medications that lower pressure by the same amount.3PubMed Central. Effects of ACEIs Versus ARBs on Proteinuria or Albuminuria in Primary Hypertension A Meta-Analysis of Randomized Trials
You might wonder whether combining an ACE inhibitor with an ARB would offer double the benefit. It does knock proteinuria down further, roughly an additional quarter to a third beyond monotherapy, but clinical trials found that this dual blockade also sharply raises the risk of dangerously high potassium levels and has not actually improved long-term kidney or heart outcomes. Because of that risk-benefit mismatch, dual blockade is generally not recommended.4PubMed. Prediction and management of hyperkalemia across the spectrum of chronic kidney disease
SGLT2 Inhibitors as Add-On Therapy
Originally developed for type 2 diabetes, SGLT2 inhibitors like dapagliflozin and empagliflozin have turned out to be powerful kidney protectors in their own right. These drugs work by reducing how much sugar your kidneys reabsorb, but the kidney benefit appears to come from a different effect: they lower the pressure inside the kidney’s filtering units, much like ACE inhibitors do but through a separate pathway. Trial data show that SGLT2 inhibitors decrease albuminuria and reduce the risk of kidney disease progression in people with diabetes.5PubMed. Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non-diabetic patients with chronic kidney disease (DIAMOND): a randomised, double-blind, crossover trial More recent trials have extended these benefits to people with chronic kidney disease who do not have diabetes at all.
One thing that catches people off guard is the initial “dip” in kidney function numbers after starting an SGLT2 inhibitor. Your estimated kidney filtration rate may drop by a small amount in the first weeks. This dip is considered to reflect the drug doing its job, easing pressure inside the kidney, and it is generally reversible.6PubMed. Characterization and implications of the initial estimated glomerular filtration rate ‘dip’ upon sodium-glucose cotransporter-2 inhibition with empagliflozin in the EMPA-REG OUTCOME trial If your doctor warns you about a small change on your next lab work after starting one of these drugs, that is usually why.
Finerenone and Other Newer Medications
Finerenone is a newer drug that blocks the mineralocorticoid receptor, which plays a role in inflammation and scarring within the kidney. Unlike older drugs in the same family (like spironolactone), finerenone is non-steroidal, which means it carries a lower risk of hormonal side effects and appears to cause less hyperkalemia and fewer treatment dropouts than the older versions.7PubMed Central. Renal Protection of Mineralocorticoid Receptor Antagonist, Finerenone, in Diabetic Kidney Disease In large trials involving nearly 14,000 participants, finerenone significantly reduced the urine albumin-to-creatinine ratio compared with placebo, with reductions becoming more pronounced after three months of treatment.8Kidney International Reports. The Role of Finerenone in Cardiorenal Protection and Urine Albumin-to-Creatinine Ratio Modulation A real-world study in patients with kidney disease but without diabetes found a median reduction in 24-hour urine protein of about 60%.9PubMed Central. Proteinuria reduction by and safety of finerenone in Chinese patients with CKD without diabetes: a real-world retrospective study
GLP-1 receptor agonists, the class that includes semaglutide and liraglutide, are another emerging option. A pooled analysis of major trials found that semaglutide and liraglutide lowered albuminuria by about a quarter compared with placebo over two years, with the higher dose of semaglutide achieving the largest reduction of roughly a third.10PubMed Central. Effect of the Glucagon-Like Peptide-1 Receptor Agonists Semaglutide and Liraglutide on Kidney Outcomes in Patients With Type 2 Diabetes: Pooled Analysis of SUSTAIN 6 and LEADER A separate analysis across multiple GLP-1 receptor agonist trials found an average albuminuria reduction of about 16% compared with controls.11PubMed Central. Effect of glucagon-like peptide 1 receptor agonists on albuminuria in adult patients with type 2 diabetes mellitus: A systematic review and meta-analysis These drugs are currently used mainly in people who also have diabetes or obesity, but their kidney benefits are prompting research into broader applications.
For certain kidney diseases like IgA nephropathy, sparsentan represents a specialized approach. It blocks both the endothelin receptor and the angiotensin receptor simultaneously, targeting two pathways that drive protein leakage. Early case series have shown notable reductions in proteinuria when sparsentan is used, sometimes in combination with other drugs like SGLT2 inhibitors.12PubMed Central. Case Report: Maximizing the anti-proteinuric response: a multicenter real-world sparsentan case series in IgA disorders
Cutting Sodium Does More Than You Might Expect
Dietary sodium restriction is one of the most underappreciated tools for reducing proteinuria. A randomized trial compared adding a low-sodium diet to an ACE inhibitor versus adding a second blood pressure drug (an ARB) to the same ACE inhibitor. The low-sodium diet reduced proteinuria by about half, while adding the second drug cut it by only about a fifth. In other words, the diet change was more than twice as effective as adding another medication.13PubMed Central. Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial Combining the low-sodium diet with both drugs produced the best result, but the diet alone did most of the heavy lifting.
The practical target is usually a moderate sodium intake, often framed as less than about 2,000 mg per day. This does not mean food has to be bland. Most excess sodium comes from processed and packaged foods, restaurant meals, and sauces rather than from the salt shaker at the table. Swapping canned soups for homemade versions, choosing fresh or frozen vegetables over canned, and reading labels for sodium content can get you most of the way there without dramatic sacrifice.
How Much Protein You Eat and What Kind
This can feel counterintuitive: if your kidneys are leaking protein, why would eating less of it help? The reason is that a high-protein diet increases the workload on your kidneys. More protein in your bloodstream means higher pressure inside the kidney’s filtering units, which accelerates damage and drives more protein into the urine. A low-protein diet, generally around 0.6 to 0.8 grams per kilogram of body weight per day, is recommended for people with chronic kidney disease to counter this effect.14PubMed Central. How important is dietary management in chronic kidney disease progression? A role for low protein diets For someone who weighs about 70 kilograms (roughly 155 pounds), that translates to roughly 42 to 56 grams of protein per day, which is less than many people eat but not as restrictive as it might sound.
One study of patients with advanced diabetic kidney disease found that a low-protein diet supplemented with keto-acid analogs (building blocks that the body can convert into amino acids without the nitrogen waste that taxes the kidneys) reduced proteinuria about threefold and slowed the decline in kidney function about fivefold.15PubMed Central. Low Protein Diet Reduces Proteinuria and Decline in Glomerular Filtration Rate in Advanced, Heavy Proteinuric Diabetic Kidney Disease These are impressive numbers, though they come from patients with severe disease, so the magnitude of benefit may be larger than what someone with mild proteinuria would see.
The type of protein you eat also matters. A head-to-head comparison of animal versus plant protein found that animal-protein diets increased kidney filtration rate and the amount of albumin leaking through the filters compared with plant-based protein. After a meat meal, kidney blood flow jumped by about 14 to 16%, while a soy-based meal produced no such spike.16PubMed. Renal, metabolic and hormonal responses to ingestion of animal and vegetable proteins This does not mean you need to go fully vegetarian, but shifting some of your protein sources from red meat toward legumes, tofu, or other plant foods can reduce the strain on already-compromised kidneys.
Broader Dietary Patterns
Rather than obsessing over single nutrients, adopting a whole dietary pattern may be more sustainable and more protective. A study of women with type 2 diabetes found that those who closely followed a Mediterranean-style diet had dramatically lower odds of developing diabetic kidney disease, with high adherence linked to about an 86% reduction in odds. High adherence to the DASH diet (Dietary Approaches to Stop Hypertension) was also protective, though to a lesser degree.17PubMed. Dietary approaches to stop hypertension, mediterranean dietary pattern, and diabetic nephropathy in women with type 2 diabetes: A case-control study Both patterns emphasize fruits, vegetables, whole grains, and healthy fats while limiting processed foods and sodium, which aligns well with the kidney-friendly principles discussed above.
One caveat for people with advanced kidney disease: both diets are rich in potassium from fruits and vegetables. If your kidney function is significantly reduced, your body may struggle to excrete potassium, making high-potassium diets risky. This is where a renal dietitian becomes valuable. They can help you capture the benefits of these patterns while managing the potassium and phosphorus limits that come with more advanced stages of kidney disease.
Weight Loss and Exercise
Carrying excess weight is an independent driver of proteinuria. Fat tissue produces inflammatory signals and hormones that raise the pressure inside the kidney’s filters, and obesity itself can cause a form of kidney disease even without diabetes. A systematic review of weight-loss interventions found that losing weight reduced proteinuria by an average of about 1.7 grams, and even small amounts mattered: each kilogram of weight lost was associated with about a 110-milligram decrease in proteinuria, independent of any blood pressure improvement.18Nephrology Dialysis Transplantation. Weight loss and proteinuria: systematic review of clinical trials and comparative cohorts
Adding exercise to a weight-loss program appears to amplify the kidney benefit. A trial comparing diet-only weight loss to diet plus exercise in obese individuals with metabolic syndrome found that both groups reduced albuminuria, but the exercise group saw greater improvements in kidney filtration rate and inflammatory markers.19Journal of Hypertension. Exercise augments weight loss induced improvement in renal function in obese metabolic syndrome individuals The mechanisms include reduced activity of the hormonal system that drives kidney pressure, lower inflammation, and better insulin sensitivity.20PubMed. Weight loss and proteinuria
Blood Pressure Targets for People With Proteinuria
Tight blood pressure control matters more when you have significant protein in your urine than when you do not. The landmark Modification of Diet in Renal Disease Study found that achieving a lower blood pressure goal significantly reduced proteinuria in the first few months, which then correlated with a slower loss of kidney function over time.21PubMed. Blood pressure control, proteinuria, and the progression of renal disease: The Modification of Diet in Renal Disease Study A patient-level meta-analysis reinforced this, finding that a systolic blood pressure in the 110 to 129 range was associated with the lowest risk of kidney disease getting worse, and that the benefit of tighter control was most pronounced in people excreting more than a gram of protein per day.22PubMed. Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis If your proteinuria is mild, a standard blood pressure target may be sufficient, but if it is heavy, your doctor may push for a tighter goal.
Watching for Hyperkalemia
Nearly every effective proteinuria medication raises your risk of hyperkalemia, or dangerously high potassium. ACE inhibitors, ARBs, SGLT2 inhibitors, and finerenone all affect potassium handling to varying degrees. Monotherapy with an ACE inhibitor or ARB usually does not cause major problems unless your kidney function is already reduced below a certain threshold or you become dehydrated.4PubMed. Prediction and management of hyperkalemia across the spectrum of chronic kidney disease But as drugs are layered together for maximal proteinuria reduction, the cumulative potassium risk climbs. Newer potassium-binding medications like patiromer and sodium zirconium cyclosilicate have made it more feasible to maintain patients on these kidney-protective drugs without having to stop them because of high potassium.23PubMed. Hyperkalemia in Chronic Kidney Disease in the New Era of Kidney Protection Therapies If you are on a combination regimen, regular blood tests for potassium are not optional. They are part of the treatment.
Supplements That Might Help and One That Probably Does Not
Active vitamin D analogs (prescription forms like paricalcitol, not the over-the-counter vitamin D3 you take for bone health) have shown a real effect on proteinuria when added to standard treatment. A systematic review found that active vitamin D analogs reduced proteinuria by about 16% from baseline, while control groups saw a slight increase.24PubMed Central. Active vitamin D treatment for reduction of residual proteinuria: a systematic review These are prescription drugs that your nephrologist would manage, not something to start on your own.
Omega-3 fatty acids from fish oil have a more ambiguous track record. A systematic review and meta-analysis found no statistically significant overall effect of omega-3 supplementation on proteinuria, though the authors noted enough variability in individual responses to suggest some specific populations might benefit.25PubMed Central. Role of omega-3 fatty acids in reducing proteinuria: A systematic review and meta-analysis A separate narrative review did find a modest reduction in proteinuria specifically in patients with IgA nephropathy.26Journal of Nephropathology. Omega-3 polyunsaturated fatty acid supplementation in chronic kidney disease; effects on inflammation, proteinuria, and renal function – a narrative review study So the honest summary is that fish oil is unlikely to hurt and may help in certain kidney conditions, but it is not a reliable proteinuria treatment for most people.
Astragalus, a root used in traditional Chinese medicine, has been studied as an add-on to standard kidney disease therapy. A Cochrane review found it reduced 24-hour proteinuria when used alongside conventional treatments, but flagged serious concerns about the quality of the studies, noting that definitive conclusions could not be drawn.27PubMed Central. Astragalus (a traditional Chinese medicine) for treating chronic kidney disease A larger meta-analysis of astragalus formulas for membranous nephropathy showed more substantial proteinuria reductions but suffered from similarly high heterogeneity across studies.28PubMed Central. Astragalus membranaceus formula for moderate-high risk idiopathic membranous nephropathy: A meta-analysis If you are interested in exploring this, it is worth discussing with your nephrologist rather than self-prescribing, both because the evidence is preliminary and because herbal preparations can interact with kidney medications.
Tracking Your Own Progress at Home
Waiting months between lab visits to find out whether your proteinuria is improving can feel like flying blind. Home urine dipstick testing is an option that is gaining traction, particularly for people with conditions like lupus nephritis or childhood nephrotic syndrome where protein levels can change rapidly. A feasibility study of a smartphone-connected home urinalysis system found that 98% of patients reported being satisfied with it, compared with only 40% who were satisfied with traditional in-clinic urine monitoring.29PubMed Central. Dipping at home: is it better, easier, and more convenient? A feasibility and acceptability study of a novel home urinalysis using a smartphone application Dipsticks cannot replace formal lab testing, since they give a rough estimate rather than precise quantification. But they can alert you early to a flare or reassure you that treatment is holding steady, which is especially useful if your condition tends to fluctuate.
Standard urine dipsticks are inexpensive and available over the counter. You dip the strip in a urine sample, wait the indicated time, and compare the color change to the chart on the bottle. A first-morning sample is most reliable. Keep in mind that dehydration can make readings look worse than reality, and very dilute urine can mask protein that is actually there. If you see a persistent change over several days, that is worth calling your doctor about rather than adjusting your own medications.